Drreddys Laboratories | Kostnadene For Salg



Cost Of Sales Endring Dato
ANI Pharmaceuticals USD 80.28M 68.05M 2024-12
Aurora Cannabis CAD 78.85M 891K 2024-12
Bayer EUR 5.72B 633M 2024-12
Canopy Growth CAD 50.66M 9.51M 2024-12
Cipla INR 22.64B 189.3M 2024-12
Corcept Therapeutics USD 2.96M 89K 2024-12
Drreddys Laboratories INR 34.53B 2.14B 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
Hikma Pharmaceutical USD 813M 39M 2024-06
Lonza CHF 1.94B 858M 2024-06
Novartis USD 3.32B 90M 2024-12
Pacira USD 39.89M 1.02M 2024-12
Prestige Brands USD 129.27M 2.86M 2024-12
Richter Gedeon HUF 69.06B 5.08B 2024-09
Sun Pharmaceuticals INR 27.41B 463.4M 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Teva Pharmaceutical Industries USD 2.11B 18M 2024-12



Drreddys Laboratories Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.